vimarsana.com

Latest Breaking News On - Sidney kimmel comprehensive cancer center at johns hopkins - Page 1 : vimarsana.com

Segmenting the Utility of ADCs in NSCLC: How These Agents Are Affecting Second-Line Standards

Dr Levy on the Evolution of ADCs in NSCLC

Benjamin Philip Levy, MD, discusses the evolution of antibody-drug conjugates in non-small cell lung cancer following updated data to be read out for this treatment population throughout 2023.

Dr Anders on the Investigation of CCR4 Antagonists in Advanced Cancers

Robert Albert Anders, MD, PhD, discusses the rationale for developing CCR4 antagonists for use in patients with advanced cancers, including lymphoma and non–small cell lung cancer.

Dr Ged on the Background of the ORCHID Trial in BAP1-Mutated Metastatic RCC

Yasser Mohamed Ali Ged, MBBS, discusses the background of launching the phase 2 ORCHID trial evaluating olaparib monotherapy in patients with metastatic renal cell carcinoma harboring BAP1 or other DNA repair gene mutations.

Dr Fader on Letrozole With or Without Paclitaxel and Carboplatin in Ovarian Serous Carcinoma

Amanda Nickles Fader, MD, discusses the randomized, phase 3 NRG-GY019 trial evaluating letrozole with or without paclitaxel and carboplatin in patients with stage II to IV primary low-grade serous carcinoma of the ovary or peritoneum.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.